假心患者的抗血栓管理:当前的证据和未来的趋势
Jack C J Sun1, Michael J Davidson, Andre Lamy
1Division of Cardiac Surgery, McMaster University, Hamilton, ON, Canada. sunjc2@mcmaster.ca
Lancet (London, England)
|August 18, 2009
概括
假心脏门可以改善生活,但需要抗血栓治疗来预防血栓. 新的进展带来了希望,特别是对于那些面临不断上升的心脏膜疾病的发展中国家.
科学领域:
- 心脏病学 心脏病学
- 生物医学工程 生物医学工程
背景情况:
- 全球有超过400万人拥有假心,每年有30万人进行植入.
- 假体门提高了严重的门心脏病的存活率.
- 抗血栓治疗对于门接受者来说至关重要但具有挑战性.
研究的目的:
- 对假心患者的抗血栓疗法进行审查.
- 讨论对血栓栓塞并发症的管理.
- 为了确定膜心脏病管理的未满足需求.
主要方法:
- 关于抗血栓治疗的文献综述.
- 对当前假体门技术的分析.
- 对膜心脏病的全球趋势的评估.
主要成果:
- 抗血栓治疗对于预防血栓并发症至关重要.
- 治疗和门技术的进步正在改善患者的治疗结果.
- 由于疾病负担的增加,发展中国家是干预的关键领域.
结论:
- 改进的抗血栓策略和门技术在全球范围内有利于患者.
- 仍然存在大量未得到满足的需求,特别是在发展中国家.
- 未来的努力应侧重于公平获得膜心脏病的先进治疗方法.
相关概念视频
Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Rheumatic Heart Disease III: Medical Management
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Endocarditis III: Medical Management
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
Mitral Valve Prolapse II: Assessment and Management
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
